FIGURE 3
Naïve B subsets analysis in IgAN patients compared with HSs and controls. PBMCs were isolated from the peripheral blood of 36 IgAN patients, 13 HSs and 22 patients with non-IgA glomerulonephritis (controls) and analysed by flow cytometry. The gating strategy used to identify lymphocytes (A, left panel), CD19+ B cells (A, right panel) and B-cell subsets (A, lower panel) is shown for one representative IgAN patient. For each B-cell subset we then analysed the expression of IgA and/or CCR9 and integrin β7 as shown in the panels.

Naïve B subsets analysis in IgAN patients compared with HSs and controls. PBMCs were isolated from the peripheral blood of 36 IgAN patients, 13 HSs and 22 patients with non-IgA glomerulonephritis (controls) and analysed by flow cytometry. The gating strategy used to identify lymphocytes (A, left panel), CD19+ B cells (A, right panel) and B-cell subsets (A, lower panel) is shown for one representative IgAN patient. For each B-cell subset we then analysed the expression of IgA and/or CCR9 and integrin β7 as shown in the panels.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close